OTTAWA, Nov. 21, 2017 /CNW/ - The Canadian Centre on Substance Use and Addiction (CCSA) is pleased to announce the appointmentof Mr. Glenn Brimacombe to Vice-president, Strategic Partnerships and Priorities, a new executive leadership role within the organization. Mr. Brimacombe will officially assume this position on January
Mr. Brimacombe comes to CCSA from the Canadian Psychiatric Association (CPA), where he was Chief Executive Officer. Previously, he was President and Chief Executive Officer for the Association of Canadian Academic Healthcare Organizations, now known as HealthCareCAN.
"I am delighted to welcome Glenn to the CCSA team as our new vice-president of Strategic Partnerships and Priorities," said Rita Notarandrea, CEO of CCSA. "The issues surrounding substance use and addiction are complex and consequential. To address them requires an approach that involves having everyone at the table. For nearly three decades, Glenn has cultivated these kinds of strategic partnerships in the healthcare sector and I am so pleased that we will soon bring his talent and expertise to CCSA and to the individuals and organizations we serve."
For thirty years, CCSA has been at the forefront of knowledge mobilization, bridging the gap and connecting the dots between people, issues and resources across Canada on matters of substance use and addiction. As the only pan-Canadian health organization with a mandate to explore the effects of both licit and illicit substances on the health and safety of Canadians, CCSA has built a strong reputation and an even stronger network of stakeholders with a common goal of reducing the harms of substance use on Canadian society and the economy.
Mr. Brimacombe is uniquely positioned to assume this new role and advance this important work. Throughout his career, his focus has been on the management of strategic policy issues related to the organization, financing and delivery of healthcare, and the federal role in research, innovation and commercialization, as well as the identification, development and nurturing of a number of strategic alliances.
"I'm honoured to join a highly reputable national health agency that has an impressive track record in helping individuals and working with partners to achieve results on substance use and addiction," said Mr. Brimacombe. "In my role as vice-president, and drawing on my past roles and experiences as a CEO of two national health organizations, I look forward to working in strategic partnership with a broad number of stakeholders to advance research, policy and practice on the services and supports to address substance use in Canada to the benefit of all Canadians."
Mr. Brimacombe holds a master's degree in economics from the University of Ottawa.
Previous Positions of Glenn Brimacombe
CCSA is Canada's only agency with a legislated national mandate to reduce the harms of alcohol and other drugs on Canadians. We do so by gathering the latest evidence and promoting that evidence widely. Created by an Act of Parliament in 1988, CCSA's vision is for a healthier Canadian society where evidence transforms approaches to substance use. Our mission is to address issues of substance use by providing national leadership and harnessing the power of evidence to generate coordinated action to inform policy, practice and programs.
The Canadian Centre on Substance Use and Addiction changes lives by bringing people and knowledge together to reduce the harm of alcohol and other drugs on society. We partner with public, private and non-governmental organizations to improve the health and safety of Canadians.
CCSA activities and products are made possible through a financial contribution from Health Canada. The views of CCSA do not necessarily represent the views of the Government of Canada.
SOURCE Canadian Centre on Substance Use and Addiction
Subscribe to our Free Newsletters!
Bladder neck incision is a surgical procedure where cuts are made in the neck of the urinary ...
Tourette syndrome (TS) is a neurological disorder wherein the affected person makes repetitive and ...
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...View All